SlideShare une entreprise Scribd logo
1  sur  22
Showcase your accomplishments!
Stacey Johnson, ASETeacher Monitor
Preparing for the ASE Symposium,
Friday, August 16th at UP
prepare * practice * prepare * practice
What Happens AtThe Symposium?
• Introductions and Keynote Speaker
• Oral Presentations
• Lunch and Recognitions
• Poster Presentations
• Networking
2019 ASE Symposium
• Dress
• Oral Presentations
• SymposiumTitle &
Registration
• Poster
• ASE Summary
• ThankYou Letter
saturdayacademy.org/ase-symposium
What’s coming up?
Oral Presentations
• Sessions have 3-4 presentations
• 10-30 attendees per session
• Each talk is 12 minutes
• Plus 3 minutes for questions
• Joint talks allowed (doubles time)
https://www.youtube.com/watch?v=S5c1susCPAE
• Model a speaker you like
• Pose a question or tell a story
• Use simple terms & clean design
• Think about your audience
CyaberAcademy: ContentPreparing & Giving your Presentation
CyaberAcademy: Content
https://www.ted.com/talks/camille_seaman_photos_from_a_storm_chaser
Presentation Style
Enjoyable?
Feedback?
Questions?
Thinking about Good Presentations
• Prepare an outline
• Use story, build background
• Think about your title
• “We’ve GotYour Rack: Discovering Engineering at
Yakima Products Inc.”
• “Risky Business”
• “An Analysis of the Conductivity of Encap Polymer
AdhesivesThrough Impedance Spectroscopy”
• “Recovery and Digitization of HistoricTide Data“
Register online by July 22nd
SymposiumTitle & Registration: examples
CyaberAcademy: Content
saturdayacademy.org/current-interns
MakingYour Poster – Details
• Follow ASE poster rules
• Check out the handbook…
“Preparing for the ASE Symposium”
CyaberAcademy: ContentMakingYour Poster - Displays
• Two posters will
hang on a stand
with binder clips.
• Do NOT use
cardboard or foam
core board
 3 ft   3 ft 
CyaberAcademy: ContentExample Format
 Start Now!
CyaberAcademy: ContentPoster Activity
• Look at the following posters
• Focus on first impressions
 What do you like about these posters?
 What is distracting or hard to read about
these posters?
Screening Synthetic Analogs of Pactamycin for Anti-Cancer
Properties in Melanoma
Asha Pantula1, Evan Carpenter2, Monet Miller2, Gitali Ganguli-Indra2,3,4, Arup Indra2,3,4,5
Background
Materials
Results
Future Developments
Acknowledgments
• Melanoma: One of the most
dangerous and treatment
resistant human cancers (1).
Before treatment 15 weeks of Vemurafenib (treatment) 32 weeks of
Vemurafenib
Need: To find a potent yet still
efficient therapy(2).
• Pactamycin: a natural
compound with many
anticancer properties and
high cytotoxicity levels (4).
• Synthetic analogs have been
produced, hoping to lower
toxicity levels (3,4).
 Worked with A375 line of human melanoma cells
 Added analogs of Pactamycin and Vehicle (DMSO)
1. TM026 is a positive control
2. TM117 and TM118: different analogs of Pactamycin
 Screened compounds through high throughput characterization
Added cell titer glow reagent which measures ATP
(cell energy) and gives ATP count
 Bright-field microscopy to identify impact on morphology
 Immunocytochemistry to observe impact on proliferation
• Analogs showing anti-
cancer properties (TM026,
TM122, and TM123) will be
tested on normal human
melanocytes, to test toxicity
levels.
• There will also be new
research on the mechanism
of action of these
compounds as well as the
morphology of the cells.
• TM026 showed strong anti-
cancer properties against
melanoma like previously
shown in head and neck
squamous cell carcinoma
cells
• TM122, and TM123 showed
strong anti-cancer traits
against metastatic
melanoma.
• TM117, TM118, TM119,
TM120, TM121, TM124, and
TM125 analogs had no
impact on the growth of the
metastatic melanoma,
A375 line of Melanoma
containing BRAF (V600E)
mutation, analogs of Pactamycin,
Growth Media (DMEM),Vehicle
(DMSO), Cell Titer Glo Assay kit
Methods
Figure A: Graph shows
that TM026 has an IC-50
value of 3.045 uM . Neither
TM117 nor TM118 showed
any anti-cancer activity in
A375 cell line.
I would like to thank Saturday
Academy for the opportunity, the
College of Pharmacy at OSU,
and all the members of the Indra
lab for their help and support.
Objective
Figure B: TM122, TM123
and TM026 all showed
anti-cancer activity against
melanoma cells.
References
1Nikolaou, Vasiliki A. et al. Melanoma: New Insights and New Therapies." J Invest Dermatol.
2012 Mar;132(3 Pt 2):854-63.
2Wagle, Nikhil, et al. "Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by
Tumor Genomic Profiling." Journal of Clinical Onocology 29.22 (2011): 3085-096.
3Lu W, Roongsawang N, Mahmud T. Biosynthetic Studies and Genetic Engineering of
Pactamycin Analogs with Improved Selectivity toward Malarial Parasites. Chem Biol.
2011;18: 425–431. pmid:21513878
.
1Saturday Academy, 2College of Pharmacy, 3Linus Pauling Institute, Oregon State University; Corvallis, OR
4Dept. of Dermatology, 5Knight Cancer Institute, Oregon Health & Sciences University; Portland, OR
Conclusions
Figure C: Bright-field microscopy shows compound TM026’s
(right) ability to kill melanoma cells thereby reducing cell density,
and reduce cell size and shape.
Figure D: Immunocytochemistry using anti-Ki67 antibody exhibits
reduced proliferation of TM026 treated melanoma cells compared
to the vehicle control.
A.
B.
E.
Figure E: Graph shows less cells treated
with TM026 inhibit Ki67 (marker for
proliferation)
Effect of TM026 on
Proliferation
- 4 - 3 - 2 - 1 0 1 2
0
2 5
5 0
7 5
1 0 0
1 2 5
E f f e c t o f P a c t a m y c i n A n a l o g s o n A 3 7 5 l i n e
L o g D o s e C o n c e n t r a t i o n
%CellSurvival
T M 0 2 6
T M 1 1 7
T M 1 1 8
P a c t a m y c i n A n a l o g u e D o s e R e s p o n s e C u r v e i n A 3 7 5
l o g [ C o m p o u n d ] (  M )
%CellSurvival
- 4 - 3 - 2 - 1 0 1 2
0
2 5
5 0
7 5
1 0 0
1 2 5
T M 0 2 6
T M 1 1 7
T M 1 1 8
T M 1 1 9
T M 1 2 0
T M 1 2 1
T M 1 2 2
T M 1 2 3
T M 1 2 4
T M 1 2 5
U.S. Melanoma Incidence*. Digital image. Planning Cancer.
N.p., n.d. Web.
To determine if synthetic analogs of
Pactamycin have anti-cancer
properties and less toxicity levels
against human metastatic melanoma.
Poster 1:
CyaberAcademy: Content
• Symposium prep = HOMEWORK
• Review poster and presentation with mentor(s)
• Practice your talk and timing
• Practice some more…
• …then, practice again
• Rehearse but don’t recite
.
Tips for Presentation Success
Poster 2:
CyaberAcademy: Content
• Stand to the side of poster – not in front
• Remember the tips from the presentation video
• Remain at your poster entire session
• Prepare your “pitch” ahead of time…
Tips for Poster Session
CyaberAcademy: ContentSupport for Symposium Success
• ASE Symposium Handbook
• Teacher Monitor
• Mentors
CyaberAcademy: ContentSummary Report
In your words…
• Your work and contributions over
the summer.
• Likely to share content with
poster and talk.
Submit Online Wed., Aug. 21st
CyaberAcademy: ContentThankYou Letters: Expressing Gratitude
Personalized & Specific
“ Your patience and sense of humor made the
long hours seem short”
Sincere & Heartfelt
“Seeing you and other scientists enthusiastic
about science has inspired my own interest.”
Gratitude & Appreciation
“I appreciate you giving me this amazing
opportunity and mentoring me!”
 Discuss title and content with mentor ASAP
 Register by Mon., Jul. 22nd
 ASE will email you a list of thank you letter
recipients by end of July
 Email your letters to yourTeacher Monitor by
Friday., Aug. 9th
 Bring signedThankYou Letters to Symposium on
Fri., Aug. 16th
 Submit Summary by Wed., Aug. 21st
Next Steps
… follow your curiosity!
Questions???

Contenu connexe

Similaire à Saturday Academy ASE Program Symposium Preparation 2019

MDC Connect: In-Silico Drug Design - what to do, what not to do - project dri...
MDC Connect: In-Silico Drug Design - what to do, what not to do - project dri...MDC Connect: In-Silico Drug Design - what to do, what not to do - project dri...
MDC Connect: In-Silico Drug Design - what to do, what not to do - project dri...Medicines Discovery Catapult
 
Running head Summary of research articles Summary of research.docx
Running head Summary of research articles Summary of research.docxRunning head Summary of research articles Summary of research.docx
Running head Summary of research articles Summary of research.docxagnesdcarey33086
 
8 CME-Accredited Conferences in Singapore - laboratory
8 CME-Accredited Conferences in Singapore - laboratory 8 CME-Accredited Conferences in Singapore - laboratory
8 CME-Accredited Conferences in Singapore - laboratory Cheryl Prior
 
CoMPARA: Collaborative Modeling Project for Androgen Receptor Activity
CoMPARA: Collaborative Modeling Project for Androgen Receptor ActivityCoMPARA: Collaborative Modeling Project for Androgen Receptor Activity
CoMPARA: Collaborative Modeling Project for Androgen Receptor ActivityKamel Mansouri
 
289161214 vietnam-2-64-tổ-chức-lớp-viết-bao-khoa-học-y-khoa-đăng-tren-tạp-chi...
289161214 vietnam-2-64-tổ-chức-lớp-viết-bao-khoa-học-y-khoa-đăng-tren-tạp-chi...289161214 vietnam-2-64-tổ-chức-lớp-viết-bao-khoa-học-y-khoa-đăng-tren-tạp-chi...
289161214 vietnam-2-64-tổ-chức-lớp-viết-bao-khoa-học-y-khoa-đăng-tren-tạp-chi...trangphan159
 
Module 01 Content1. Top of FormCompetencyExplain principle
Module 01 Content1. Top of FormCompetencyExplain principleModule 01 Content1. Top of FormCompetencyExplain principle
Module 01 Content1. Top of FormCompetencyExplain principleIlonaThornburg83
 
PEGS China-2016-Brochure
PEGS China-2016-BrochurePEGS China-2016-Brochure
PEGS China-2016-BrochureNicole Proulx
 
Powerpoint Presentation!
Powerpoint Presentation!Powerpoint Presentation!
Powerpoint Presentation!Nathan Burton
 
How predictive models help Medicinal Chemists design better drugs_webinar
How predictive models help Medicinal Chemists design better drugs_webinarHow predictive models help Medicinal Chemists design better drugs_webinar
How predictive models help Medicinal Chemists design better drugs_webinarAnn-Marie Roche
 
How To Drive Clinical Improvement Programs That Get Results - HAS Session 20
How To Drive Clinical Improvement Programs That Get Results - HAS  Session 20How To Drive Clinical Improvement Programs That Get Results - HAS  Session 20
How To Drive Clinical Improvement Programs That Get Results - HAS Session 20Health Catalyst
 
Make better drug discovery decisions through collaborative analytics cdd we...
Make better drug discovery decisions through collaborative analytics   cdd we...Make better drug discovery decisions through collaborative analytics   cdd we...
Make better drug discovery decisions through collaborative analytics cdd we...Lixin Liu
 
2nd Epigenetics Discovery congress - Latest agenda
2nd Epigenetics Discovery congress - Latest agenda2nd Epigenetics Discovery congress - Latest agenda
2nd Epigenetics Discovery congress - Latest agendaTony Couch
 
Consensus Models to Predict Endocrine Disruption for All Human-Exposure Chemi...
Consensus Models to Predict Endocrine Disruption for All Human-Exposure Chemi...Consensus Models to Predict Endocrine Disruption for All Human-Exposure Chemi...
Consensus Models to Predict Endocrine Disruption for All Human-Exposure Chemi...Kamel Mansouri
 
42_Cytopathology.pdf
42_Cytopathology.pdf42_Cytopathology.pdf
42_Cytopathology.pdfVamsi kumar
 
Drug Discovery & Development Overview
Drug Discovery & Development OverviewDrug Discovery & Development Overview
Drug Discovery & Development OverviewMikeSumner
 

Similaire à Saturday Academy ASE Program Symposium Preparation 2019 (20)

SET PROJECT PPT.pptx
SET PROJECT PPT.pptxSET PROJECT PPT.pptx
SET PROJECT PPT.pptx
 
MDC Connect: In-Silico Drug Design - what to do, what not to do - project dri...
MDC Connect: In-Silico Drug Design - what to do, what not to do - project dri...MDC Connect: In-Silico Drug Design - what to do, what not to do - project dri...
MDC Connect: In-Silico Drug Design - what to do, what not to do - project dri...
 
Running head Summary of research articles Summary of research.docx
Running head Summary of research articles Summary of research.docxRunning head Summary of research articles Summary of research.docx
Running head Summary of research articles Summary of research.docx
 
Nov1 webinar intro_slides v
Nov1 webinar intro_slides vNov1 webinar intro_slides v
Nov1 webinar intro_slides v
 
Research design
Research designResearch design
Research design
 
8 CME-Accredited Conferences in Singapore - laboratory
8 CME-Accredited Conferences in Singapore - laboratory 8 CME-Accredited Conferences in Singapore - laboratory
8 CME-Accredited Conferences in Singapore - laboratory
 
CoMPARA: Collaborative Modeling Project for Androgen Receptor Activity
CoMPARA: Collaborative Modeling Project for Androgen Receptor ActivityCoMPARA: Collaborative Modeling Project for Androgen Receptor Activity
CoMPARA: Collaborative Modeling Project for Androgen Receptor Activity
 
289161214 vietnam-2-64-tổ-chức-lớp-viết-bao-khoa-học-y-khoa-đăng-tren-tạp-chi...
289161214 vietnam-2-64-tổ-chức-lớp-viết-bao-khoa-học-y-khoa-đăng-tren-tạp-chi...289161214 vietnam-2-64-tổ-chức-lớp-viết-bao-khoa-học-y-khoa-đăng-tren-tạp-chi...
289161214 vietnam-2-64-tổ-chức-lớp-viết-bao-khoa-học-y-khoa-đăng-tren-tạp-chi...
 
Module 01 Content1. Top of FormCompetencyExplain principle
Module 01 Content1. Top of FormCompetencyExplain principleModule 01 Content1. Top of FormCompetencyExplain principle
Module 01 Content1. Top of FormCompetencyExplain principle
 
PEGS China-2016-Brochure
PEGS China-2016-BrochurePEGS China-2016-Brochure
PEGS China-2016-Brochure
 
Powerpoint Presentation!
Powerpoint Presentation!Powerpoint Presentation!
Powerpoint Presentation!
 
13 using powerpoint
13 using powerpoint13 using powerpoint
13 using powerpoint
 
13 using powerpoint
13 using powerpoint13 using powerpoint
13 using powerpoint
 
How predictive models help Medicinal Chemists design better drugs_webinar
How predictive models help Medicinal Chemists design better drugs_webinarHow predictive models help Medicinal Chemists design better drugs_webinar
How predictive models help Medicinal Chemists design better drugs_webinar
 
How To Drive Clinical Improvement Programs That Get Results - HAS Session 20
How To Drive Clinical Improvement Programs That Get Results - HAS  Session 20How To Drive Clinical Improvement Programs That Get Results - HAS  Session 20
How To Drive Clinical Improvement Programs That Get Results - HAS Session 20
 
Make better drug discovery decisions through collaborative analytics cdd we...
Make better drug discovery decisions through collaborative analytics   cdd we...Make better drug discovery decisions through collaborative analytics   cdd we...
Make better drug discovery decisions through collaborative analytics cdd we...
 
2nd Epigenetics Discovery congress - Latest agenda
2nd Epigenetics Discovery congress - Latest agenda2nd Epigenetics Discovery congress - Latest agenda
2nd Epigenetics Discovery congress - Latest agenda
 
Consensus Models to Predict Endocrine Disruption for All Human-Exposure Chemi...
Consensus Models to Predict Endocrine Disruption for All Human-Exposure Chemi...Consensus Models to Predict Endocrine Disruption for All Human-Exposure Chemi...
Consensus Models to Predict Endocrine Disruption for All Human-Exposure Chemi...
 
42_Cytopathology.pdf
42_Cytopathology.pdf42_Cytopathology.pdf
42_Cytopathology.pdf
 
Drug Discovery & Development Overview
Drug Discovery & Development OverviewDrug Discovery & Development Overview
Drug Discovery & Development Overview
 

Dernier

Judging the Relevance and worth of ideas part 2.pptx
Judging the Relevance  and worth of ideas part 2.pptxJudging the Relevance  and worth of ideas part 2.pptx
Judging the Relevance and worth of ideas part 2.pptxSherlyMaeNeri
 
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxGrade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxChelloAnnAsuncion2
 
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITYISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITYKayeClaireEstoconing
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Mark Reed
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for BeginnersSabitha Banu
 
ACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfSpandanaRallapalli
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designMIPLM
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSJoshuaGantuangco2
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17Celine George
 
ENGLISH6-Q4-W3.pptxqurter our high choom
ENGLISH6-Q4-W3.pptxqurter our high choomENGLISH6-Q4-W3.pptxqurter our high choom
ENGLISH6-Q4-W3.pptxqurter our high choomnelietumpap1
 
ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4MiaBumagat1
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Celine George
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxthorishapillay1
 
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...JhezDiaz1
 
Science 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxScience 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxMaryGraceBautista27
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Celine George
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Celine George
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptxmary850239
 

Dernier (20)

Judging the Relevance and worth of ideas part 2.pptx
Judging the Relevance  and worth of ideas part 2.pptxJudging the Relevance  and worth of ideas part 2.pptx
Judging the Relevance and worth of ideas part 2.pptx
 
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxGrade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
 
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITYISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for Beginners
 
ACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdf
 
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptxYOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-design
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17
 
ENGLISH6-Q4-W3.pptxqurter our high choom
ENGLISH6-Q4-W3.pptxqurter our high choomENGLISH6-Q4-W3.pptxqurter our high choom
ENGLISH6-Q4-W3.pptxqurter our high choom
 
ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptx
 
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
 
Science 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxScience 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptx
 
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptxYOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx
 

Saturday Academy ASE Program Symposium Preparation 2019

  • 1. Showcase your accomplishments! Stacey Johnson, ASETeacher Monitor Preparing for the ASE Symposium, Friday, August 16th at UP
  • 2. prepare * practice * prepare * practice What Happens AtThe Symposium? • Introductions and Keynote Speaker • Oral Presentations • Lunch and Recognitions • Poster Presentations • Networking
  • 4. • Dress • Oral Presentations • SymposiumTitle & Registration • Poster • ASE Summary • ThankYou Letter saturdayacademy.org/ase-symposium What’s coming up?
  • 5. Oral Presentations • Sessions have 3-4 presentations • 10-30 attendees per session • Each talk is 12 minutes • Plus 3 minutes for questions • Joint talks allowed (doubles time) https://www.youtube.com/watch?v=S5c1susCPAE
  • 6. • Model a speaker you like • Pose a question or tell a story • Use simple terms & clean design • Think about your audience CyaberAcademy: ContentPreparing & Giving your Presentation
  • 8. Thinking about Good Presentations • Prepare an outline • Use story, build background • Think about your title
  • 9. • “We’ve GotYour Rack: Discovering Engineering at Yakima Products Inc.” • “Risky Business” • “An Analysis of the Conductivity of Encap Polymer AdhesivesThrough Impedance Spectroscopy” • “Recovery and Digitization of HistoricTide Data“ Register online by July 22nd SymposiumTitle & Registration: examples
  • 10. CyaberAcademy: Content saturdayacademy.org/current-interns MakingYour Poster – Details • Follow ASE poster rules • Check out the handbook… “Preparing for the ASE Symposium”
  • 11. CyaberAcademy: ContentMakingYour Poster - Displays • Two posters will hang on a stand with binder clips. • Do NOT use cardboard or foam core board  3 ft   3 ft 
  • 13. CyaberAcademy: ContentPoster Activity • Look at the following posters • Focus on first impressions  What do you like about these posters?  What is distracting or hard to read about these posters?
  • 14. Screening Synthetic Analogs of Pactamycin for Anti-Cancer Properties in Melanoma Asha Pantula1, Evan Carpenter2, Monet Miller2, Gitali Ganguli-Indra2,3,4, Arup Indra2,3,4,5 Background Materials Results Future Developments Acknowledgments • Melanoma: One of the most dangerous and treatment resistant human cancers (1). Before treatment 15 weeks of Vemurafenib (treatment) 32 weeks of Vemurafenib Need: To find a potent yet still efficient therapy(2). • Pactamycin: a natural compound with many anticancer properties and high cytotoxicity levels (4). • Synthetic analogs have been produced, hoping to lower toxicity levels (3,4).  Worked with A375 line of human melanoma cells  Added analogs of Pactamycin and Vehicle (DMSO) 1. TM026 is a positive control 2. TM117 and TM118: different analogs of Pactamycin  Screened compounds through high throughput characterization Added cell titer glow reagent which measures ATP (cell energy) and gives ATP count  Bright-field microscopy to identify impact on morphology  Immunocytochemistry to observe impact on proliferation • Analogs showing anti- cancer properties (TM026, TM122, and TM123) will be tested on normal human melanocytes, to test toxicity levels. • There will also be new research on the mechanism of action of these compounds as well as the morphology of the cells. • TM026 showed strong anti- cancer properties against melanoma like previously shown in head and neck squamous cell carcinoma cells • TM122, and TM123 showed strong anti-cancer traits against metastatic melanoma. • TM117, TM118, TM119, TM120, TM121, TM124, and TM125 analogs had no impact on the growth of the metastatic melanoma, A375 line of Melanoma containing BRAF (V600E) mutation, analogs of Pactamycin, Growth Media (DMEM),Vehicle (DMSO), Cell Titer Glo Assay kit Methods Figure A: Graph shows that TM026 has an IC-50 value of 3.045 uM . Neither TM117 nor TM118 showed any anti-cancer activity in A375 cell line. I would like to thank Saturday Academy for the opportunity, the College of Pharmacy at OSU, and all the members of the Indra lab for their help and support. Objective Figure B: TM122, TM123 and TM026 all showed anti-cancer activity against melanoma cells. References 1Nikolaou, Vasiliki A. et al. Melanoma: New Insights and New Therapies." J Invest Dermatol. 2012 Mar;132(3 Pt 2):854-63. 2Wagle, Nikhil, et al. "Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling." Journal of Clinical Onocology 29.22 (2011): 3085-096. 3Lu W, Roongsawang N, Mahmud T. Biosynthetic Studies and Genetic Engineering of Pactamycin Analogs with Improved Selectivity toward Malarial Parasites. Chem Biol. 2011;18: 425–431. pmid:21513878 . 1Saturday Academy, 2College of Pharmacy, 3Linus Pauling Institute, Oregon State University; Corvallis, OR 4Dept. of Dermatology, 5Knight Cancer Institute, Oregon Health & Sciences University; Portland, OR Conclusions Figure C: Bright-field microscopy shows compound TM026’s (right) ability to kill melanoma cells thereby reducing cell density, and reduce cell size and shape. Figure D: Immunocytochemistry using anti-Ki67 antibody exhibits reduced proliferation of TM026 treated melanoma cells compared to the vehicle control. A. B. E. Figure E: Graph shows less cells treated with TM026 inhibit Ki67 (marker for proliferation) Effect of TM026 on Proliferation - 4 - 3 - 2 - 1 0 1 2 0 2 5 5 0 7 5 1 0 0 1 2 5 E f f e c t o f P a c t a m y c i n A n a l o g s o n A 3 7 5 l i n e L o g D o s e C o n c e n t r a t i o n %CellSurvival T M 0 2 6 T M 1 1 7 T M 1 1 8 P a c t a m y c i n A n a l o g u e D o s e R e s p o n s e C u r v e i n A 3 7 5 l o g [ C o m p o u n d ] (  M ) %CellSurvival - 4 - 3 - 2 - 1 0 1 2 0 2 5 5 0 7 5 1 0 0 1 2 5 T M 0 2 6 T M 1 1 7 T M 1 1 8 T M 1 1 9 T M 1 2 0 T M 1 2 1 T M 1 2 2 T M 1 2 3 T M 1 2 4 T M 1 2 5 U.S. Melanoma Incidence*. Digital image. Planning Cancer. N.p., n.d. Web. To determine if synthetic analogs of Pactamycin have anti-cancer properties and less toxicity levels against human metastatic melanoma. Poster 1:
  • 15. CyaberAcademy: Content • Symposium prep = HOMEWORK • Review poster and presentation with mentor(s) • Practice your talk and timing • Practice some more… • …then, practice again • Rehearse but don’t recite . Tips for Presentation Success Poster 2:
  • 16. CyaberAcademy: Content • Stand to the side of poster – not in front • Remember the tips from the presentation video • Remain at your poster entire session • Prepare your “pitch” ahead of time… Tips for Poster Session
  • 17. CyaberAcademy: ContentSupport for Symposium Success • ASE Symposium Handbook • Teacher Monitor • Mentors
  • 18. CyaberAcademy: ContentSummary Report In your words… • Your work and contributions over the summer. • Likely to share content with poster and talk. Submit Online Wed., Aug. 21st
  • 19. CyaberAcademy: ContentThankYou Letters: Expressing Gratitude Personalized & Specific “ Your patience and sense of humor made the long hours seem short” Sincere & Heartfelt “Seeing you and other scientists enthusiastic about science has inspired my own interest.” Gratitude & Appreciation “I appreciate you giving me this amazing opportunity and mentoring me!”
  • 20.
  • 21.  Discuss title and content with mentor ASAP  Register by Mon., Jul. 22nd  ASE will email you a list of thank you letter recipients by end of July  Email your letters to yourTeacher Monitor by Friday., Aug. 9th  Bring signedThankYou Letters to Symposium on Fri., Aug. 16th  Submit Summary by Wed., Aug. 21st Next Steps
  • 22. … follow your curiosity! Questions???